An Inactivated Novel Trivalent Vaccine Provides Complete Protection against FAdV-4 Causing Hepatitis-Hydropericardium Syndrome and FAdV-8b/-11 Causing Inclusion Body Hepatitis

<div>The rFAdV-4-fiber/8b + 11 replicated efficiently in LMH cells. LMH cells were infected with rFAdV-4-fiber/8b + 11 and wild-type FAdV-4 at same dose (MOI = 0.001), respectively, and the TCID<sub>50</sub> of each virus collected at the indicated time points was determined in three technical replicates and presented as the mean ± standard error of mean.</div>

Transboundary and Emerging Diseases

fig2

Figure 2

Figure 2: An Inactivated Novel Trivalent Vaccine Provides Complete Protection against FAdV-4 Causing Hepatitis-Hydropericardium Syndrome and FAdV-8b/-11 Causing Inclusion Body Hepatitis 

Figure 2 | An Inactivated Novel Trivalent Vaccine Provides Complete Protection against FAdV-4 Causing Hepatitis-Hydropericardium Syndrome and FAdV-8b/-11 Causing Inclusion Body Hepatitis 